Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba

Journal of Genetic Counseling

Volumn 16, Issue 4, 2007, Pages 469-479

  Paneque, Milena ^a,b   Lemos, Carolina ^c   Escalona, Karell ^a   Prieto, Lizandra ^a   Reynaldo, Rubén ^a   Velázquez, Mercedes ^a   Quevedo, Judith ^a   Santos, Nieves ^a   Almaguer, Luis Enrique ^a   Velázquez, Luis ^a   Sousa, Alda ^c   Fleming, Manuela ^b,c   Sequeiros, Jorge ^b,c  

^a Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anxiety; Depression; Family functioning; Hereditary ataxia; Late onset neurological disorders; Predictive testing; Psychosocial genetics

Indexed keywords

CYSTEINE PROTEINASE; SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; CUBA; DEPRESSION; FAMILY FUNCTIONING; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC RISK; HEREDITARY ATAXIA; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PSYCHOLOGICAL ASPECT; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR DEGENERATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANXIETY; CUBA; DEPRESSION; FAMILY PLANNING SERVICES; FAMILY RELATIONS; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MOTIVATION; NERVE TISSUE PROTEINS; PROSPECTIVE STUDIES; SPINOCEREBELLAR ATAXIAS;

EID: 34548163596     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-006-9083-y     Document Type: Article

References (47)

1. Almqvist, E., Bloch, M., Brinkman, R., Craufurd, D., & Hayden, M., on behalf of an international HD collaborative group (1999). A worldwide assessment of the frequency of suicide attempts, or psychiatric hospitalization after predictive testing for HD. Am J Hum Genet, 64, 1293-1304.
2. Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R., The Canadian Collaborative Study of Predictive Testing (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin Genet, 64, 300-309.
3. Babul, R., Adam, S., Kremer, B., Dufrasne, S., Wiggins, S., & Huggins, M. (1993). Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA, 19, 2321-2325.
4. Beck, T., Ward, C., & Mendelson, M. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 4, 561-571.
5. Bloch, M., Adam, S., Wiggins, S., Huggins, M., & Hayden, M. (1992). Predictive testing for Huntington's disease in Canada: The experience of those receiving an increased risk. Am J Med Genet, 42, 499-507.
6. Bloch, M., Fahy, M., Fox, S., & Hayden M. (1989). Predictive testing for Huntington's disease: Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one tests candidates. Am J Med Genet, 32, 217-224.
7. Brandt, J., Quaid, K., Folstein S., Garber, P., Maestri, N., Abbott, M., et al. (1989). Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. JAMA, 261, 3108-3114.
8. Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Gen, 8, 731-738.
9. Brower-DudokdeWit, A., Savenije, A., Zoeteweij, M., Maat Kievit, A., & Tibben, A. (2000). A hereditary disorder in the family and the family life cycle: Huntington Disease as a paradigm. Fam Process, Winter.
10. Bonke, B., Smorenburg, J., & Kors Van Der Ent, C. (1987) Evidence of denial and item-intensity specificity in the State-Trait Anxiety Inventory. Person Individ Diff, 8, 185-191.
11. Codori, A., Hanson, R., & Brandt, J. (1994). Self-selection in predictive testing for Huntington's disease. Am J Med Genet, 54, 167-173.
12. Codori, A. M., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997). Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol, 16, 36-50.
13. Codori, A. M., Slavney, P. R., Rossenblatt, A., & Brandt, J. (2004). Prevalence of major depression one year after predictive testing for Huntington's disease. Genet Test, 8, 114-119.
14. Craufurd, D., Kerzin-Storrar, L., & Harris, R. (1989). Uptake of presymptomatic predictive testing for Huntington's disease. Lancet, 2, 603-605.
15. De la Cuesta, F., Ortega, T., & Días, C. (1999). Propuesta de un instrumento para la aplicación del proceso de atención de enfermería en familias disfuncionales. Rev Cub Enfer, 15, 164-168.
16. Decruyenaere, M., Evers-Kiebooms, G., & Boogaerts, A. (1996). Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the result on reproductive decision making. J Med Gen, 33, 737-743.
17. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J., Cloostermans, T., Demyttenaere, K., et al. (1995). Predictive testing for Huntington's disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Counsel, 6, 1-13.
18. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J., Cloostermans, T., Demyttenaere, K., et al. (1999). Psychological functioning before predictive testing for Huntington's disease: The role of the parental disease, risk perception, and subjective proximity of the disease. J Med Gen, 36, 897-905.
19. Duisterhof, M., Trijsburg, R., Niermeijer, M., Roos, R., & Tibben, A. (2001). Psychological studies in Huntington's disease: Making up the balance. J Med Gent, 38, 852-861.
20. European Community Huntington Disease Collaborative Study Group. (1993). Ethical and social issues in presymptomatic testing for Huntington's disease: A European Community collaborative study. J Med Genet, 30, 1028-1035.
21. Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington's disease: A challenge for persons at risk and for professionals. Patient Educ Counsel, 35, 15-26.
22. Fleming, M., Lêdo, S., Rocha, J., & Sequeiros, J. (2004). Impacto psicológico do teste predictivo na doença de Machado Joseph: Resultados preliminares. Arq Medicina, 18, 72-75.
23. Gispert, S., Twells, R., Orozco, G., Brice, A., Wever, J., & Heredero, L. (1993). Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet, 4, 29-59.
24. Goizet, C., Lesca, G., & Dürr, A., on behalf of the French Group for Presymptomatic Testing in Neurogenetic Disorders. (2002). Presymptomatic testing for Huntington's disease and autosomal dominant cerebellar ataxias. Neurology, 59, 1330-1336.
25. Gonzalez, C., Lima, M., Kay, T., Silva, C., Santos, C., & Santos, J. (2004). Short-term psychological impact of predictive testing for Machado-Joseph disease: Depression and anxiety levels in individuals at risk from the Azores (Portugal). Community Genet, 7, 196-201.
26. Huggins, M., Bloch, M., Wiggins, S., Adam, S., Suchowersky, O., Trew, M., et al. (1992). Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet, 42, 508-515.
27. Kessler, S. (1994). Predictive testing for Huntington disease: A psychologist's view [editorial comment]. Am J Med Genet, 54, 161-166.
28. Laccone, F., Engel, U., Holinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington disease: Five years of experience in Germany, Austria and Switzerland. Neurology, 53, 801-806.
29. Marteau, M. T., & Croyle R. T. (1998). The new genetics: Psychological responses to genetic testing. BMJ, 28, 693-696.
30. Meissen, J., Mastromauro, A., Kiely, K., McNamara, S., & Myers, H. (1991). Understanding the decision to take the predictive test for Huntington's disease. Am J Med Genet, 39, 404-410.
31. Orozco, G., Nodarse, A., Cordovés, R., & Aurburger, G. (1990). Autosomal dominant cerebellar ataxia: Clinical analysis of 263 patients from a homogeneous population in Holguín, Cuba. Neurology, 40, 1369-1375.
32. Paneque, M., Prieto, L., Reynaldo, R., Cruz, T., Santos, N., Almaguer, L., et al. (2006). Presymptomatic diagnosis of spinocerebellar ataxia type 2 in Cuba: A preliminary valoration. Community Genet (in press).
33. Pulst, S. M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X. N., Lopes-Cendes, I., et al. (1996). Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet, 14, 269-276.
34. Quaid, A., & Wesson, M. (1995). Exploration of the effects of Predictive testing for Huntington disease on intimate relationships. Am J Med Genet, 57, 46-51.
35. Rapaport, D., Schafer, R., & Gill, M. M. (1946). Diagnostic Psychological Testing. Chicago, Ill: Year Book Publishers.
36. Rolim, L., Leite, A., Ledo, S., Paneque, M., Sequeiros, J., & Fleming, M. (2006). Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. Clin Genet, 69, 297-305.
37. Rolland, S., & Williams, J. (2005). Toward a biopsychosocial model for 21st century genetics. Fam Process, 44, 3-24.
38. Sequeiros, J. (1996). Protocolo Geral do Programa Nacional de Teste Preditivo e o aconselhamento Genético na Doença de Machado-Joseph. In J. Sequeiros (Ed.), O Teste Preditivo da Doença de Machado-Joseph (pp. 123-149). Porto: UnIGENe, IBMC.
39. Sobel, S., & Cowan, D. B. (2003). Ambiguous loss and disenfranchised grief: The impact of DNA predictive testing on the family as a system. Fam Process, 42, 47-57.
40. Solís-Pérez, M., Burguesa, J., Palau, F., Livianos, L., Vila, M., & Rojo, L. (2001). Resultados de un programa de diagnóstico presintomático en la enfermedad de Huntington: Evaluación de un período de 6 años. Rev Neurol Esp, 16, 348-352.
41. Spielberger, D., Gorsuch, L., & Lushene, E. (Eds.). (1970). Manual for the Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychological Press.
42. Tibben, A., Vegter-vd Vlis, M., Skraastad, I., Frets, G., Kamp, P., Niermeijer, F., et al. (1992). DNA testing for Huntington disease in The Netherlands: A retrospective study on psychosocial effects. Am J Med Genet, 44, 94-99.
43. Tibben, A. (1993). What is knowledge but grieving? On psychological effects of presymptomatic DNA-testing for Huntington's disease. PhD thesis. Erasmus University of Rotterdam.
44. Tibben, A., Duivenvoorden, M., Martinus, F., Niermeijer, F., Van Der Vlis, M. V., Roos, R. A., et al. (1994). Psychological effects of presymptomatic DNA Testing for Huntington's disease in the Dutch program. Psychosomatic Med, 56, 526-532.
45. Tibben, A., Timman, R., Bannink, C., & Duivenvoorden, J. (1997). Tree year follow-up after presymptomatic testing for HD in tested individuals and partners. Health Psych, 16, 20-35.
46. Velázquez, L., Santos, N., García, R., Paneque, M., & Hechavarría, R. (2001). Epidemiología de la ataxia hereditaria cubana. Rev Neurol Esp, 32, 606-611.
47. Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., et al. (1992). The psychological consequences of predictive testing for Huntington's disease. N Engl J Med, 327, 1401-1405.